Biblio

Export 3180 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
A. Julian, Rioux-Bilan, A., Ragot, S., Krolak-Salmon, P., Berrut, G., Dantoine, T., Hommet, C., Hanon, O., Page, G., and Paccalin, M., “Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 87-92, 2018.
W. Tarraf, Rodríguez, C. J., Daviglus, M. L., Lamar, M., Schneiderman, N., Gallo, L., Talavera, G. A., Kaplan, R. C., Fornage, M., Conceicao, A., and González, H. M., “Blood Pressure and Hispanic/Latino Cognitive Function: Hispanic Community Health Study/Study of Latinos Results.”, J Alzheimers Dis, vol. 59, no. 1, pp. 31-42, 2017.
D. A. Levine, Gross, A. L., Briceño, E. M., Tilton, N., Whitney, R., Han, D., Giordani, B. J., Sussman, J. B., Hayward, R. A., Burke, J. F., Elkind, M. S. V., Moran, A. E., Tom, S., Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., Sacco, R. L., Heckbert, S. R., Hughes, T. M., Lopez, O. L., Allen, N. Bai, and Galecki, A. T., “Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.
N. Voyle, Baker, D., Burnham, S. C., Covin, A., Zhang, Z., Sangurdekar, D. P., Hehir, C. A. Tan, Bazenet, C., Lovestone, S., Kiddle, S., and Dobson, R. J. B., “Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.”, J Alzheimers Dis, 2015.
D. R. Galasko, Grill, J. D., Lingler, J. H., and Heidebrink, J. L., “A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?”, J Alzheimers Dis, vol. 90, no. 3, pp. 963-966, 2022.
S. J. Kiddle, Voyle, N., and Dobson, R. J. B., “A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.”, J Alzheimers Dis, vol. 64, no. s1, pp. S289-S297, 2018.
T. K. Karikari, “Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.”, J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
J. Olazarán, Gil-de-Gómez, L., Rodríguez-Martín, A., Valentí-Soler, M., Frades-Payo, B., Marín-Muñoz, J., Antúnez, C., Frank-García, A., Jiménez, C. Acedo, Gracia, L. Morlén, Torregrossa, R. Petidier, Guisasola, M. Concepció, Bermejo-Pareja, F., Sánchez-Ferro, Á., Pérez-Martínez, D. A., Palomo, S. Manzano, Farquhar, R., Rábano, A., and Calero, M., “A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H., “Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
S. Westwood, Leoni, E., Hye, A., Lynham, S., Khondoker, M. R., Ashton, N. J., Kiddle, S. J., Baird, A. L., Sainz-Fuertes, R., Leung, R., Graf, J., Hehir, C. Tan, Baker, D., Cereda, C., Bazenet, C., Ward, M., Thambisetty, M., and Lovestone, S., “Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.”, J Alzheimers Dis, vol. 52, no. 2, pp. 561-72, 2016.
I. K. Gorham, Reid, D. Marie, Sun, J., Zhou, Z., Barber, R. C., and Phillips, N. R., “Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1407-1419, 2024.
S. M. Williams, Schulz, P., Rosenberry, T. L., Caselli, R. J., and Sierks, M. R., “Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 23-35, 2017.
A. Malishkevich, Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., and Gozes, I., “Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.”, J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.
D. L. Ebel, Torkilsen, C. G., and Ostrowski, T. D., “Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1197-1211, 2017.
L. Smith, Shin, J. Il, Oh, H., Carmichael, C., Jacob, L., Stefanac, S., Lindsay, R. K., Soysal, P., Veronese, N., Tully, M. A., Butler, L., Barnett, Y., and Koyanagi, A., “Body Mass Index and Mild Cognitive Impairment Among Middle-Aged and Older Adults from Low- and Middle-Income Countries.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1095-1105, 2021.
H. Jang, Kim, J. Hun, Choi, S. Hye, Lee, Y., Hong, C. Hyung, Jeong, J. Hyang, Han, H. Jeong, Moon, S. Young, Park, K. Won, Han, S. - H., Park, K. Hyung, Kim, H. Jin, Na, D. L., and Seo, S. Won, “Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease.”, J Alzheimers Dis, 2015.
I. Cohen-Manheim, Doniger, G. M., Sinnreich, R., Simon, E. S., Murad, H., Pinchas-Mizrachi, R., and Kark, J. D., “Body Mass Index, Height, and Socioeconomic Position in Adolescence, Their Trajectories into Adulthood, and Cognitive Function in Midlife.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1207-1221, 2017.
S. Kawanishi, Takata, K., Itezono, S., Nagayama, H., Konoya, S., Chisaki, Y., Toda, Y., Nakata, S., Yano, Y., Kitamura, Y., and Ashihara, E., “Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 563-585, 2018.
A. G. Senejani, Maghsoudlou, J., El-Zohiry, D., Gaur, G., Wawrzeniak, K., Caravaglia, C., Khatri, V. A., MacDonald, A., and Sapi, E., “Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues.”, J Alzheimers Dis, vol. 85, no. 2, pp. 889-903, 2021.
M. Malek-Ahmadi, Perez, S. E., Chen, K., and Mufson, E. J., “Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 1, pp. 189-197, 2020.
P. Mecocci, Baroni, M., Senin, U., and Boccardi, V., “Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?”, J Alzheimers Dis, vol. 64, no. s1, pp. S397-S404, 2018.
E. Fiorenzato, Biundo, R., Cecchin, D., Frigo, A. Chiara, Kim, J., Weis, L., Strafella, A. P., and Antonini, A., “Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.”, J Alzheimers Dis, vol. 66, no. 1, pp. 229-237, 2018.
W. Wang, Lu, L., Wu, Q. - Q., and Jia, J. - P., “Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1089-99, 2016.
H. - J. Kim, Im, H. Kyun, Kim, J., Han, J. - Y., de Leon, M., Deshpande, A., and Moon, W. - J., “Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1101-9, 2016.
Y. Kuttner-Hirshler, Venkatasubramanian, P. N., Apolinario, J., Bonds, J., Wyrwicz, A. M., and Lazarov, O., “Brain Biomarkers in Familial Alzheimer's Disease Mouse Models.”, J Alzheimers Dis, vol. 60, no. 3, pp. 949-958, 2017.

Pages